Jeil Pharmaceutical Co Ltd Market Cap ($86.90 Million)
Market Cap & Net Worth: Jeil Pharmaceutical Co Ltd (271980)
Jeil Pharmaceutical Co Ltd market cap. Jeil Pharmaceutical Co Ltd (KO:271980) has a market capitalization of $86.90 Million (₩128.23 Billion) as of November 4, 2026. Listed on the KO stock exchange, this Korea-based company holds position #19528 globally and #980 in its home market, demonstrating a -1.91% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Jeil Pharmaceutical Co Ltd's stock price ₩8720.00 by its total outstanding shares 14704872 (14.70 Million). Also see Jeil Pharmaceutical Co Ltd (271980) cash flow conversion for how efficiently the company converts equity into cash flow.
Jeil Pharmaceutical Co Ltd Market Cap History (2017–2026)
Jeil Pharmaceutical Co Ltd market cap history from 2017 to 2026. Data shows change from $436.83 Million to $86.90 Million (-16.44% CAGR). Check Jeil Pharmaceutical Co Ltd share price for real-time trading data and today's change.
Jeil Pharmaceutical Co Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Jeil Pharmaceutical Co Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore Jeil Pharmaceutical Co Ltd (271980) net asset momentum to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
0.00x
Jeil Pharmaceutical Co Ltd's market cap is 0.00 times its annual revenue
Latest Price to Earnings (P/E) Ratio
0.01x
Jeil Pharmaceutical Co Ltd's market cap is 0.01 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2017 | $436.83 Million | $371.59 Billion | $1.07 Billion | 0.00x | 0.41x |
| 2018 | $459.57 Million | $627.07 Billion | $1.89 Billion | 0.00x | 0.24x |
| 2019 | $357.70 Million | $671.41 Billion | -$10.58 Billion | 0.00x | N/A |
| 2020 | $619.29 Million | $691.32 Billion | $6.92 Billion | 0.00x | 0.09x |
| 2021 | $335.49 Million | $700.69 Billion | -$12.47 Billion | 0.00x | N/A |
| 2022 | $208.65 Million | $722.23 Billion | -$13.09 Billion | 0.00x | N/A |
| 2023 | $170.41 Million | $726.39 Billion | $5.00 Billion | 0.00x | 0.03x |
| 2024 | $113.60 Million | $704.54 Billion | -$29.97 Billion | 0.00x | N/A |
| 2025 | $150.97 Million | $567.24 Billion | $23.38 Billion | 0.00x | 0.01x |
Competitor Companies of 271980 by Market Capitalization
Companies near Jeil Pharmaceutical Co Ltd in the global market cap rankings as of November 4, 2026. Also see how large is Jeil Pharmaceutical Co Ltd's balance sheet for a full breakdown of the balance sheet.
Key companies related to Jeil Pharmaceutical Co Ltd by market ranking:
- Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #509 globally with a market cap of $52.60 Billion USD.
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #534 globally with a market cap of $50.42 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #580 globally with a market cap of $46.03 Billion USD ( CN¥314.55 Billion CNY).
- Takeda Pharmaceutical Company Limited (F:TKDA): Ranked #618 globally with a market cap of $43.60 Billion USD ( €37.29 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #509 | Takeda Pharmaceutical Co Ltd ADR | NYSE:TAK | $52.60 Billion | $16.65 |
| #534 | GALDERMA GROUP AG | NYSE:GALDY | $50.42 Billion | $45.90 |
| #580 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $46.03 Billion | CN¥49.31 |
| #618 | Takeda Pharmaceutical Company Limited | F:TKDA | $43.60 Billion | €18.50 |
Market Capitalization of Jeil Pharmaceutical Co Ltd (2017–2026)
Market capitalization of Jeil Pharmaceutical Co Ltd from 2017 to today. Between 2017 and today, Jeil Pharmaceutical Co Ltd's market cap moved from $436.83 Million to $ 86.90 Million, with a yearly change of -16.44%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | ₩86.90 Million | -42.44% |
| 2025 | ₩150.97 Million | +32.89% |
| 2024 | ₩113.60 Million | -33.33% |
| 2023 | ₩170.41 Million | -18.33% |
| 2022 | ₩208.65 Million | -37.81% |
| 2021 | ₩335.49 Million | -45.83% |
| 2020 | ₩619.29 Million | +73.13% |
| 2019 | ₩357.70 Million | -22.17% |
| 2018 | ₩459.57 Million | +5.21% |
| 2017 | ₩436.83 Million | -- |
End of Day Market Cap According to Different Sources
On Nov 4th, 2026 the market cap of Jeil Pharmaceutical Co Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $86.90 Million USD |
| MoneyControl | $86.90 Million USD |
| MarketWatch | $86.90 Million USD |
| marketcap.company | $86.90 Million USD |
| Reuters | $86.90 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Jeil Pharmaceutical Co Ltd
Jeil Pharmaceutical Co.,Ltd develops and supplies pharmaceutical products primarily in South Korea and internationally. It provides products in the areas of antibiotic, gastrointestinal, cardiovascular, neuropsychiatry, oncology, endocrinology, urology, antiviral, and antihistamine. The company exports its products. Jeil Pharmaceutical Co.,Ltd was founded in 1959 and is headquartered in Seoul, So… Read more